Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
47520 studies found for:    Open Studies | Senior
Show Display Options
Rank Status Study
1 Not yet recruiting Acute Dyspnea After Use of Non-invasive Ventilation in COPD and Emphysema (Deventilation Syndrome)
Condition: Obstructive Chronic Bronchitis
2 Recruiting Application-based Perioperative Management of the Radical Cystectomy Patient
Condition: Radical Cystectomy
Intervention: Other: LifeScience Technologies application
3 Not yet recruiting Phase I Study of Ixazomib and Erlotinib in Solid Tumors
Condition: Advanced Solid Tumors
Interventions: Drug: Ixazomib;   Drug: Erlotinib
4 Recruiting Bevacizumab in the Treatment of Malignant Pleural Effusions of Non-squamous Non-small Cell Lung Cancer
Condition: Malignant Pleural Effusion
Intervention: Drug: Bevacizumab
5 Recruiting Motivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation (MISOAC-AF)
Conditions: Patient Compliance;   Patient Adherence
Interventions: Behavioral: Motivational interview;   Behavioral: Control
6 Recruiting Comparative Noninvasive Continuous Cardiac Output by the Clearsight® With Invasive Monitoring by PICCO® in Abdominal Major Surgery
Condition: Cardiac Output Measurement
Intervention: Device: Cardiac output and stroke ejection volume monitoring with both ClearSight® and PICCO® in major abdominal surgery.
7 Not yet recruiting Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Postmenopausal Women With HR+ HER2- aBC
Condition: Breast Cancer
Interventions: Drug: Ribociclib (LEE011);   Drug: Letrozole
8 Recruiting Compare Between Two Doses of Palonosetron on the Prevention of Postoperative Nausea and Vomiting in Obese Patients
Condition: Postoperative Nausea and Vomiting
Intervention: Drug: palonosetron
9 Not yet recruiting Determining of Normal Values and Conformity Assessment of the Dosage of a Plasmatic Marker of the Cellular Captation of Glucose: the IRAP Protein
Condition: Insulin Resistance
Intervention: Other: Blood sample collection during an OGTT to assess IRAP blood concentration
10 Not yet recruiting Ambroxol in Disease Modification in Parkinson Disease
Condition: Parkinson Disease
Intervention: Drug: Ambroxol
11 Not yet recruiting Harnessing Placebo Effects in Methadone Treatment
Condition: Opioid-related Disorders
Intervention: Behavioral: Placebo Dose-Extension pill
12 Not yet recruiting Drug Use Investigation of Kovaltry in Hemophilia A Patients
Condition: Hemophilia A
Intervention: Drug: Kovaltry (Antihemophilic Factor [Recombinant], BAY81-8973)
13 Recruiting Feeding America's Bravest: Mediterranean Diet-Based Interventions to Change Firefighters' Eating Habits
Conditions: Diet, Mediterranean;   Health Behavior;   Program Sustainability;   Program Effectiveness
Intervention: Behavioral: Mediterranean diet Intervention
14 Recruiting A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases
Conditions: Stage IIIC Skin Melanoma;   Stage IV Skin Melanoma
Interventions: Drug: nivolumab;   Drug: ipilimumab
15 Not yet recruiting Examination of Sleep, Smoking Cessation, and Cardiovascular Health
Condition: Nicotine Dependence
Interventions: Behavioral: Sleep Advancement Counseling;   Behavioral: General Health Information
16 Not yet recruiting Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: HCP1202;   Drug: HGP1011;   Drug: HCP0910
17 Recruiting Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip
Condition: Osteonecrosis
18 Not yet recruiting The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults
Conditions: Hearing Loss;   Deafness
Intervention: Device: Neuro Cochlear Implant System
19 Not yet recruiting Implementing Systematic Distress Screening in Breast Cancer
Condition: Breast Cancer
Intervention: Behavioral: Distress screening
20 Not yet recruiting A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)
Conditions: Locally Advanced Squamous Non-Small Cell Lung Cancer;   Metastatic Squamous Non-Small Cell Lung Cancer
Interventions: Drug: Necitumumab;   Drug: Gemcitabine;   Drug: Carboplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years